Advertisements

Zycel 100/Zycel 200

Quick links to important sections

Zycel 100/Zycel 200

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Zycel 100/Zycel 200

Quick Facts

Property Description
Active ingredient Celecoxib
Form Hard Gelatin Capsule
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common purpose Analgesic, Anti-inflammatory, and Antipyretic action
Origin Synthetic (Diaryl-substituted pyrazole derivative)

What Type of Medicine is Zycel 100/Zycel 200?

Zycel 100 and Zycel 200 are prescription-only medicines defined by the active chemical substance Celecoxib, which is delivered in a fixed amount inside a Hard Gelatin Capsule for Oral administration. This medicine is a single active ingredient product where the numbers 100 or 200 denote the specific quantity of the active compound in milligrams present in each capsule. The brand, often associated with the manufacturer Zydus Cadila, is recognized as a clinically supported option for systemic relief.

Classification and Mechanism

Zycel 100/Zycel 200 is classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID) and, more specifically, a selective cyclooxygenase-2 (COX-2) inhibitor, a drug type often referred to as a coxib. Celecoxib is a synthetic compound derived from a diaryl-substituted pyrazole structure and contains a sulfonamide functional group. This classification distinguishes Celecoxib from older, non-selective NSAIDs by allowing it to primarily target only the COX-2 enzyme, which is responsible for mediating pain and inflammation. This means the drug is designed to focus its action on the specific enzyme that causes the discomfort.

The core benefit of the medicine is to provide symptomatic relief by intervening directly in the biological process that causes pain and inflammation. Celecoxib works by disrupting the production of prostaglandins, which are the chemical messengers the body releases at sites of injury. The result of this targeted blockade is a three-pronged effect: analgesic (pain-relieving), anti-inflammatory (swelling-reducing), and antipyretic (fever-reducing) action. For example, it is typically relied upon to help ease chronic joint discomfort and related swelling.

Advertisements

What side effects are possible with Zycel 100/Zycel 200?

Official Adverse Reactions and Safety Profile

The following safety information for Celecoxib (Zycel) is based on official government regulatory documents, detailing the classification and occurrence of possible adverse reactions.

Serious Safety Concerns

The most serious documented safety concerns relate to two major body systems. The medicine is associated with a risk of serious cardiovascular thrombotic events, including myocardial infarction (MI) and stroke, which may increase with the duration of use. Additionally, there is a risk of serious gastrointestinal events, such as bleeding, ulceration, and perforation, which can occur without warning.

Common and System-Specific Effects

Adverse reactions are officially categorized by the system they affect and their frequency in the clinical population. Common adverse reactions typically documented include hypertension (high blood pressure), peripheral oedema (swelling due to fluid retention), headache, insomnia, and common gastrointestinal disturbances such as dyspepsia and diarrhoea. Less common effects may involve the nervous system (e.g., anxiety) or cardiac system (e.g., cardiac failure).

System-Organ Class Common Adverse Reactions (Examples)
Vascular Disorders Hypertension, Exacerbation of hypertension
Gastrointestinal Disorders Dyspepsia, Diarrhoea, Abdominal pain
Nervous System Disorders Headache, Dizziness

Specific Safety Limitations

The medicine is subject to specific regulatory limitations. It is contraindicated in patients with a known allergy to sulfonamides or to aspirin or other NSAIDs. It is also prohibited for use in severe, uncontrolled heart failure. Official safety notes highlight that older adults are generally at a greater risk for serious gastrointestinal and cardiovascular events, and cardiovascular risk may be amplified with long-term exposure.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Zycel 100/Zycel 200 (Celecoxib) is generally classified by regulatory authorities as reversible but carries a documented potential risk for severe, life-threatening complications. Regulatory documentation states that, as with other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), no specific antidote is known. Management is restricted entirely to symptomatic and supportive care.

Overdose Presentation and Risk Official Regulatory Statement
Documented Symptoms Manifestations following acute overdose are typically limited to lethargy, drowsiness, nausea, vomiting, and epigastric pain (stomach pain).
Serious Outcomes The profile includes risks of gastrointestinal bleeding and perforation, acute renal failure, respiratory depression, coma, and anaphylactoid reactions
Specific Risks Elderly patients are at greater risk for serious adverse events. Poor CYP2C9 metabolizers may have increased risk due to higher drug plasma levels.
Emergency Action and Management Official Regulatory Statement
Required Urgent Action Seek immediate medical attention for any suspected overdose. Contact emergency services immediately if the patient has a seizure, collapses, or cannot be awakened.
Management Principle Treatment is symptomatic and supportive. Early intervention may involve activated charcoal or gastric lavage, though procedures like hemodialysis are documented as unlikely to be useful due to high protein binding.
Advertisements

Therapeutic Uses of Zycel 100/Zycel 200

What Zycel 100/Zycel 200 Treats: Main Uses and Benefits

Zycel 100/Zycel 200 (Celecoxib) is used for symptomatic relief across several therapeutic domains. This medication is commonly used to help manage symptoms related to inflammatory or irritative states and provides supportive relief when symptoms interfere with routine activities. The overall purpose is to provide supportive relief that helps patients cope more steadily with difficult episodes and assists with easing symptoms that create noticeable functional strain.

It is primarily applied across conditions presenting with chronic, acute, or episodic symptoms, including Osteoarthritis (OA), Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), Juvenile Rheumatoid Arthritis (JRA), acute pain following procedures or resulting from injuries, and recurrent pain like Primary Dysmenorrhea and migraine headaches. The medication helps address symptom clusters of pain, swelling, and joint stiffness that create noticeable physiological strain. It is generally relevant for managing symptoms that interfere with daily comfort.

“The medication assists with easing symptoms related to heightened physiological activity and is helpful in situations where multiple symptoms occur together.”

Quick Fact Symptom Domain
Therapeutic Context Chronic Joint Pain and Stiffness
Therapeutic Context Post-Procedural Discomfort
Therapeutic Context Cyclical and Sudden-Onset Pain

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Zycel (Celecoxib) eligibility is strictly defined by regulatory documentation, outlining populations for whom use is permitted, restricted, or strictly prohibited.

Contraindicated Populations (Absolute Prohibitions)

Use is contraindicated in patients with known hypersensitivity to celecoxib, sulfonamides, or a history of allergic reactions to Aspirin or other NSAIDs. Absolute prohibitions also apply to patients with active GI bleeding, Inflammatory Bowel Disease, severe hepatic dysfunction (Child-Pugh ge 10), Congestive Heart Failure (NYHA Class II-IV), and those receiving treatment for peri-operative pain following CABG surgery.

Age-Related Eligibility and Restrictions

Population Group Eligibility Status
Adults Approved for use in the general adult population.
Pediatric Patients Approved for use in patients 2 years of age and older for Juvenile Rheumatoid Arthritis (JRA). Safety and efficacy not established in children under 2 years.
Older Adults No dose adjustment is generally necessary, but those with body weight <50 kg should begin therapy at the lowest recommended dose.

Organ Function and Special Restrictions

Use is not recommended in patients with severe renal impairment (creatinine clearance <30 mL/min). Patients with moderate hepatic impairment (Child-Pugh Class B) must use restricted dosing. Use is contraindicated in the third trimester of pregnancy (starting at sim30 weeks) and during breastfeeding (lactation), as stated in official labeling.


Connection to the overall eligibility profile

Regulatory documents define eligibility by outlining specific population groups that are contraindicated due to risks related to hypersensitivity, cardiovascular status, or organ function. Conversely, the label explicitly designates adults and certain pediatric patients as populations for whom use is established and permitted. Conditional eligibility is mandated for patients with moderate hepatic impairment or those with significant cardiovascular risk factors, requiring the application of caution.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information describes several categories of interactions for Celecoxib, the active ingredient in Zycel 100/Zycel 200, focusing on metabolic interference and pharmacodynamic reinforcement.

Interaction Type Interacting Substances/Context Regulatory Statement
Prohibited Combinations Non-Aspirin NSAIDs Use with other non-aspirin nonsteroidal anti-inflammatory drugs is not recommended, increasing the risk of gastrointestinal complications.
CABG Surgery Contraindicated for treatment of perioperative pain in the setting of coronary artery bypass graft surgery.
Pharmacokinetic Fluconazole This CYP2C9 inhibitor results in a two-fold increase in celecoxib plasma concentration (exposure).
Pharmacodynamic Warfarin / Oral Anticoagulants Co-administration increases the risk of serious bleeding events and necessitates close monitoring of anticoagulant activity.
ACE Inhibitors / ARBs / Diuretics May diminish the antihypertensive and diuretic effects of these agents.
Exposure Modification Lithium / Digoxin Celecoxib may increase the serum concentration and potential toxicity of both Lithium and Digoxin by reducing their renal clearance.
Food Interaction High-Fat Meal Delays the time to peak plasma concentration (Tmax) by one to two hours, with a slight increase in total absorption.
Timing Note Aluminum- and Magnesium-Containing Antacids Co-administration resulted in a reduction in Celecoxib plasma concentrations.

The drug's interaction profile is shaped by its metabolism via the CYP2C9 enzyme and its inherent NSAID properties, which affect platelet function and renal hemodynamics. Specific populations, such as those who are CYP2C9 poor metabolizers, have an increased risk of high plasma levels. Use with alcohol is officially documented as increasing the risk of developing gastrointestinal bleeding.

Advertisements

Mechanism of Action

Targeted Enzyme Mechanism: Selective COX-2 Inhibition

The mechanism is the selective, competitive inhibition of the Cyclooxygenase-2 (COX-2) enzyme. By binding to the COX-2 active site, the molecule prevents the conversion of Arachidonic Acid into Prostaglandins, reducing the synthesis of these mediators produced in response to inflammatory stimuli.

Pathway Cascade: Suppression of Inflammatory Mediators

Blocking COX-2 suppresses the entire Prostaglandin synthesis cascade, reducing the excessive formation of these mediators that drive vascular changes and pain signaling. This targeted suppression minimizes the physiological components of the inflammatory response, including vasodilation and fluid accumulation in tissues.

Physiological Modulation: Pain Signaling and Thermoregulation

The drug's mechanism leads to dual modulation. It raises the threshold of peripheral nociceptors (pain-sensing neurons) by reducing Prostaglandin sensitization and acts centrally within the hypothalamus to influence the body's elevated temperature set-point. The combined action modulates signaling in both peripheral and central systems, influencing systemic physiological responses.

Advertisements

Dosage and Administration Information

How to Use Zycel 100/Zycel 200: Administration Guidelines

The administration of celecoxib (the active ingredient in Zycel 100/200) is governed by instructions detailing the route, dosage ranges, frequency, and special conditions for use. This medicine is prescribed for oral administration only, typically involving the ingestion of the hard gelatin capsules.

The overarching principle for use is to utilize the lowest effective dosage for the shortest duration consistent with treatment goals.

Standard Dosing and Frequency

Indication Standard Regimen (Adults) Maximum Daily Dose (Adults)
Osteoarthritis 200 mg total (Once Daily or 100 mg Twice Daily) 400 mg
Rheumatoid Arthritis 100 mg to 200 mg Twice Daily (BID) 400 mg
Acute Pain/Dysmenorrhea 400 mg initial dose, followed by 200 mg BID (subsequent days) 400 mg (Subsequent days)

Context of Administration

The capsules can generally be taken with or without food. Administration with food is suggested for doses exceeding 200 mg twice daily to optimize absorption. For patients who experience difficulty swallowing, the capsule contents may be emptied onto a level teaspoon of applesauce and swallowed immediately, followed by water. If a dose is missed, it should be taken as soon as remembered, unless it is nearly time for the next scheduled dose, in which case the missed dose should be skipped; doses should never be doubled.

Population-Specific Adjustments

Specific dose modifications are required for certain groups. A dose reduction of approximately 50% is mandated for patients with moderate hepatic impairment (Child-Pugh Class B). Additionally, weight-based dosing is specified for use in pediatric patients with Juvenile Rheumatoid Arthritis.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies


Phase 3 Trial Analysis: Investigation and Outcomes

Phase 3 research focused on the compound's profile. The compound's profile includes inhibition of a specific enzyme pathway that was the subject of the study, and its use was investigated for its effects on symptoms of condition X in Phase 3 trials.

The research objectives included evaluating effects on pain and inflammation markers. The trial design focused on evaluating whether the compound resulted in measurable changes in participant-reported pain scores (e.g., VAS scale) and biological markers of inflammation (e.g., CRP levels).


Scope and Duration of Studies

Phase 2 studies, which included over 500 participants, examined the compound’s effects on outcome measures. Safety was a primary endpoint, with researchers recording all adverse events, including those deemed severe. The trials excluded participants with pre-existing heart conditions to align with the predefined study scope.

Clinical trial protocol involved specific parameters for absorption and co-consumption of other substances. These parameters were defined within the trial protocol.

The long-term study investigated changes in disease activity over 5 years. The research examined its characteristics when administered over an extended period. The study included a comparison of the compound against a conventional treatment to evaluate differences in recorded outcomes.

Studies reported an observation in 70% of cases, based on predefined clinical response criteria; a positive response was not guaranteed for all participants. The overall findings remain subject to further research and independent verification.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Zycel 100/Zycel 200 (FAQ)


Q: What specific conditions are treated by Zycel 100/Zycel 200?

A: Zycel is an NSAID that is officially indicated for relieving the signs and symptoms of several conditions. These include chronic conditions such as Osteoarthritis and Rheumatoid Arthritis.

It is also approved for managing short-term (acute) pain, including primary dysmenorrhea (menstrual cramps), and Juvenile Rheumatoid Arthritis in children 2 years of age and older.


Q: What is a COX-2 inhibitor, and how is it different from traditional pain relievers?

A: Zycel is a selective Cyclooxygenase-2 (COX-2) inhibitor, which is a classification within the NSAID drug class. It works by primarily blocking the COX-2 enzyme, which is responsible for producing the chemical messengers that cause pain and inflammation.

Because Zycel is selective, official documents indicate it acts on the inflammatory process by primarily inhibiting the COX-2 enzyme, distinguishing its mechanism from non-selective NSAIDs.


Q: Does Zycel 100 or 200 contain celecoxib?

A: Yes, official drug labeling confirms that the active pharmaceutical ingredient in both Zycel 100 and Zycel 200 hard gelatin capsules is celecoxib.

The numbers 100 and 200 denote the specific amount, in milligrams, of celecoxib contained in each capsule.


Q: How long does it typically take to feel pain relief after starting Zycel?

A: The onset of action can vary depending on the condition being treated. For the treatment of certain types of pain, such as menstrual cramps (primary dysmenorrhea), clinical studies indicate that some patients may begin to feel pain relief within one hour of taking the initial dose.


Q: Does Zycel help with acute or short-term pain, or is it only for chronic conditions?

A: Official labeling shows that Zycel is indicated for the management of both short-term (acute) pain and chronic inflammatory conditions.

In addition to conditions like osteoarthritis, it is approved for the treatment of acute pain and primary dysmenorrhea (menstrual cramps).


Q: Is it better to take Zycel 100/200 with or without food?

A: According to the official administration guidelines, celecoxib capsules may generally be taken with or without food.

However, regulatory information notes that administration with food may affect the time it takes for the medicine to reach its peak concentration in the bloodstream.


Q: What should I do if I miss a dose of Zycel?

A: Regulatory documents state that if a dose is missed, and it is almost time for the next scheduled dose, the instruction is to skip the missed dose and resume the regular dosing schedule.

Official patient information notes that doses should not be doubled to compensate for a missed dose.


Q: What are the signs of a serious allergic reaction to Zycel?

A: Serious allergic reactions are rare but possible. Serious signs, as detailed in official warnings, may include shortness of breath, trouble breathing, or swelling of the face, lips, or throat.

If the first appearance of any skin rash, blistering, or fever occurs, the medication should be discontinued, and the situation should be professionally assessed.


Q: Can Zycel mask signs of infection or fever?

A: Yes, because Zycel is an NSAID, it possesses antipyretic (fever-reducing) properties. Official patient information confirms that this action can potentially hide or mask some of the usual signs of an infection.

The potential for this masking effect is noted as a relevant factor during clinical evaluation, especially when signs of infection are present.


Q: Is there a risk of stomach ulcers or bleeding with Zycel, even though it's a selective NSAID?

A: Yes. While Zycel is a selective COX-2 inhibitor, it still belongs to the class of NSAIDs, which carry a potential risk of serious gastrointestinal adverse events.

Official warnings indicate this includes a risk of bleeding, ulceration, and perforation of the stomach or intestines. This risk can occur at any time during use and without any prior warning symptoms.


Q: Is Zycel safe for people with kidney or liver problems?

A: Celecoxib use requires caution in patients with pre-existing liver or kidney impairment, as noted in official regulatory documents.

Specific dosage reductions are required for people with moderate hepatic (liver) impairment, and use is generally not recommended in people with severe hepatic impairment or advanced renal (kidney) disease.


Q: Can I safely take Zycel with other over-the-counter pain relievers like acetaminophen?

A: The official product information strongly prohibits the use of Zycel alongside other non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) due to an increased risk of complications.

Due to the potential for drug interactions, the use of combination pain relief products alongside celecoxib requires professional consideration.


Q: Is it safe to use Zycel while breastfeeding?

A: Official information indicates that celecoxib is excreted into human milk in low levels.

Official information states that a professional assessment must be conducted to weigh the clinical benefits of the drug for the mother against the potential risks of exposure to the infant through breast milk.


Q: Can Zycel affect female fertility or the ability to conceive?

A: Official regulatory information notes that NSAIDs, including celecoxib, may potentially affect ovulation by delaying or preventing the rupture of ovarian follicles.

In situations where a patient is having difficulty conceiving, evaluation of the need for drug withdrawal is noted within the official product labeling.


Q: Is Zycel used for the treatment of juvenile rheumatoid arthritis (JRA) in children?

A: Yes, the official indications for Zycel include the relief of signs and symptoms of Juvenile Rheumatoid Arthritis (JRA).

Regulatory approval for this use is specified for pediatric patients who are 2 years of age and older.


Q: Is it safe to drive or operate machinery after taking Zycel?

A: While the medication is generally not expected to impair the ability to drive or operate complex machinery, caution is advised.

If adverse reactions such as dizziness or drowsiness occur, which are listed in the official safety profile, official information advises caution and avoiding activities such as driving or operating machinery.


Q: What are the long-term effects or risks associated with taking Zycel?

A: Official safety warnings indicate that the risks associated with the medicine may increase with the duration of use.

This includes the risk of serious cardiovascular thrombotic events (such as heart attack or stroke) and the risk of gastrointestinal bleeding or ulceration. Long-term use is also associated with potential injury to the kidneys.


Q: Does Zycel affect sleep or cause sleeplessness?

A: Yes, official documents list insomnia (trouble sleeping or sleeplessness) as a common adverse reaction that patients may experience while taking celecoxib.


Q: Can Zycel be used for general back pain or muscle sprains?

A: Zycel is formally indicated for the management of acute pain.

While general back pain and muscle sprains are common types of short-term pain, the regulatory approval is for the general acute pain indication.


Q: Is the celecoxib in Zycel the same as in the brand-name Celebrex?

A: Yes. Zycel and the brand-name Celebrex both contain the identical active ingredient, which is celecoxib.

They share the same pharmacological classification as a selective COX-2 inhibitor.


Q: How do the 100mg and 200mg strengths of Zycel differ in their use?

A: The two strengths are used differently depending on the patient's condition and the required total daily dose.

The strength and frequency of the dose are determined by the specific condition being managed and the clinical guidance provided.


Q: What types of allergic-type reactions should prompt me to stop taking Zycel?

A: Official documents advise that the medication should be discontinued at the first appearance of any skin rash, lesion, or signs of hypersensitivity.

Seeking a professional assessment is necessary if these signs occur, as they may be early indicators of a serious or potentially life-threatening reaction.


Q: Does Zycel interact with blood sugar medications for diabetes?

A: Interactions with medications are possible. While the official labeling does not list all specific diabetes medications, there is a potential for celecoxib to interact with certain oral hypoglycemic agents (medications used to lower blood sugar).

If a patient is taking diabetes medication, professional assessment is required due to the potential for interactions.


Q: Can Zycel be used for menstrual cramps (primary dysmenorrhea)?

A: Yes, the management of primary dysmenorrhea (menstrual cramps) is one of the formally approved indications for celecoxib.

This specific use is listed in the official indications and dosage guidelines.

Advertisements

How should Zycel 100/Zycel 200 be stored and disposed of?

Official Storage and Disposal Requirements for Zycel (Celecoxib)

The official regulatory profile for Zycel 100/Zycel 200 is based on strict, non-advisory instructions regarding its environment, stability, and handling.

Requirement Area Official Statement
Storage Temperature Store at controlled room temperature, typically below 30 C (86 F). Do not freeze or refrigerate.
Protection Keep the medicine in its container, away from moisture, excessive heat, and direct light.
Child Safety Keep out of the reach and sight of children.
Handling/Stability Capsule contents mixed with food (if applicable) must be used within 6 hours if refrigerated.
Disposal Dispose of unused or expired medicine in accordance with local and national regulations. Do not discard in household trash or down the drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Zycel 100/Zycel 200 found in:

A-Z Index: